367 related articles for article (PubMed ID: 17102078)
1. New advances in the genetics of pheochromocytoma and paraganglioma syndromes.
Gimenez-Roqueplo AP
Ann N Y Acad Sci; 2006 Aug; 1073():112-21. PubMed ID: 17102078
[TBL] [Abstract][Full Text] [Related]
2. Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes.
Benn DE; Richardson AL; Marsh DJ; Robinson BG
Ann N Y Acad Sci; 2006 Aug; 1073():104-11. PubMed ID: 17102077
[TBL] [Abstract][Full Text] [Related]
3. Novel SDHB and TMEM127 Mutations in Patients with Pheochromocytoma/Paraganglioma Syndrome.
Patócs A; Lendvai NK; Butz H; Liko I; Sapi Z; Szucs N; Toth G; Grolmusz VK; Igaz P; Toth M; Rácz K
Pathol Oncol Res; 2016 Oct; 22(4):673-9. PubMed ID: 26960314
[TBL] [Abstract][Full Text] [Related]
4. Hereditary pheochromocytoma and paraganglioma.
Mazzaglia PJ
J Surg Oncol; 2012 Oct; 106(5):580-5. PubMed ID: 22648936
[TBL] [Abstract][Full Text] [Related]
5. A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma.
Buffet A; Venisse A; Nau V; Roncellin I; Boccio V; Le Pottier N; Boussion M; Travers C; Simian C; Burnichon N; Abermil N; Favier J; Jeunemaitre X; Gimenez-Roqueplo AP
Horm Metab Res; 2012 May; 44(5):359-66. PubMed ID: 22517557
[TBL] [Abstract][Full Text] [Related]
6. Pheochromocytoma: an update on genetics and management.
Karagiannis A; Mikhailidis DP; Athyros VG; Harsoulis F
Endocr Relat Cancer; 2007 Dec; 14(4):935-56. PubMed ID: 18045948
[TBL] [Abstract][Full Text] [Related]
7. Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options.
Vicha A; Musil Z; Pacak K
Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):186-91. PubMed ID: 23481210
[TBL] [Abstract][Full Text] [Related]
8. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
[TBL] [Abstract][Full Text] [Related]
9. Uncommon clinical presentations of pheochromocytoma and paraganglioma in two different patients affected by two distinct novel VHL germline mutations.
Ercolino T; Becherini L; Valeri A; Maiello M; Gaglianò MS; Parenti G; Ramazzotti M; Piscitelli E; Simi L; Pinzani P; Nesi G; Degl'Innocenti D; Console N; Bergamini C; Mannelli M
Clin Endocrinol (Oxf); 2008 May; 68(5):762-8. PubMed ID: 18031321
[TBL] [Abstract][Full Text] [Related]
10. [Achievements of the COMETE program in the genetics of pheochromocytoma].
Gimenez-Roqueplo AP; Burnichon N; Amar L; Favier J; Jeunemaitre X; Plouin PF
Bull Acad Natl Med; 2008 Jan; 192(1):105-15; discussion 115-6. PubMed ID: 18663985
[TBL] [Abstract][Full Text] [Related]
11. Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma.
Dhir M; Li W; Hogg ME; Bartlett DL; Carty SE; McCoy KL; Challinor SM; Yip L
Ann Surg Oncol; 2017 Nov; 24(12):3624-3630. PubMed ID: 28884434
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.
Bayley JP; Weiss MM; Grimbergen A; van Brussel BT; Hes FJ; Jansen JC; Verhoef S; Devilee P; Corssmit EP; Vriends AH
Endocr Relat Cancer; 2009 Sep; 16(3):929-37. PubMed ID: 19546167
[TBL] [Abstract][Full Text] [Related]
13. Childhood phaeochromocytoma and paraganglioma: 100% incidence of genetic mutations and 100% survival.
Hammond PJ; Murphy D; Carachi R; Davidson DF; McIntosh D
J Pediatr Surg; 2010 Feb; 45(2):383-6. PubMed ID: 20152357
[TBL] [Abstract][Full Text] [Related]
14. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.
Gill AJ
Pathology; 2012 Jun; 44(4):285-92. PubMed ID: 22544211
[TBL] [Abstract][Full Text] [Related]
15. Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications.
Barletta JA; Hornick JL
Adv Anat Pathol; 2012 Jul; 19(4):193-203. PubMed ID: 22692282
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of SDHB mutations in head and neck paraganglioma in Belgium.
Persu A; Hamoir M; Grégoire V; Garin P; Duvivier E; Reychler H; Chantrain G; Mortier G; Mourad M; Maiter D; Vikkula M
J Hypertens; 2008 Jul; 26(7):1395-401. PubMed ID: 18551016
[TBL] [Abstract][Full Text] [Related]
17. Phaeochromocytoma, new genes and screening strategies.
Gimenez-Roqueplo AP; Lehnert H; Mannelli M; Neumann H; Opocher G; Maher ER; Plouin PF;
Clin Endocrinol (Oxf); 2006 Dec; 65(6):699-705. PubMed ID: 17121518
[TBL] [Abstract][Full Text] [Related]
18. New insights in the genetics of adrenocortical tumors, pheochromocytomas and paragangliomas.
Bertherat J; Gimenez-Roqueplo AP
Horm Metab Res; 2005 Jun; 37(6):384-90. PubMed ID: 16001332
[TBL] [Abstract][Full Text] [Related]
19. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes.
Gimenez-Roqueplo AP; Dahia PL; Robledo M
Horm Metab Res; 2012 May; 44(5):328-33. PubMed ID: 22328163
[TBL] [Abstract][Full Text] [Related]
20. Is genetic screening indicated in apparently sporadic pheochromocytomas and paragangliomas?
Iacobone M; Schiavi F; Bottussi M; Taschin E; Bobisse S; Fassina A; Opocher G; Favia G
Surgery; 2011 Dec; 150(6):1194-201. PubMed ID: 22136840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
